Literature DB >> 23725604

Innovative approaches for enhancing cancer gene therapy.

Shilpa Bhatia1, Mitchell E Menezes, Swadesh K Das, Luni Emdad, Santanu Dasgupta, Xiang-Yang Wang, Devanand Sarkar, Paul B Fisher.   

Abstract

Gene therapy provides a novel platform for therapeutic intervention of several genetic and non-genetic disorders. With the recent developments in the field, a wide variety of viral and non-viral vectors have emerged that can deliver genetic payloads to target cells. However, non-targeted delivery of transgenes often results in undesirable effects, low tumor transduction, and reduced therapeutic index. In this review, we focus on some of the novel approaches that can be used to meet the present challenges in the field and translate the potential of cancer gene therapy from 'bench to bedside' in the near future.

Entities:  

Mesh:

Year:  2013        PMID: 23725604

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  11 in total

Review 1.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

Review 2.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 3.  MDA-7/IL-24: multifunctional cancer killing cytokine.

Authors:  Mitchell E Menezes; Shilpa Bhatia; Praveen Bhoopathi; Swadesh K Das; Luni Emdad; Santanu Dasgupta; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

5.  The effect of interleukin 36 gene therapy in the regression of tumor.

Authors:  Shiva Solahaye-Kahnamouii; Farrokh Farhadi; Mahni Rahkare-Farshi; Farzaneh Pakdel; Atabak Kashefimehr; Firouz Pouralibaba; Gholamreza Shirani; Mohammad Bayat; Abbas Karimi
Journal:  Iran J Cancer Prev       Date:  2014

6.  Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.

Authors:  Sven Hagen; Tobias Baumann; Hanna J Wagner; Volker Morath; Beate Kaufmann; Adrian Fischer; Stefan Bergmann; Patrick Schindler; Katja M Arndt; Kristian M Müller
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

7.  Targeted breast cancer therapy by harnessing the inherent blood group antigen immune system.

Authors:  Wei Han; Wei Li; Xiaoying Zhang; Zhonghua Du; Xiaoliang Liu; Xin Zhao; Xue Wen; Guanjun Wang; Ji-Fan Hu; Jiuwei Cui
Journal:  Oncotarget       Date:  2017-02-28

Review 8.  Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.

Authors:  Luni Emdad; Swadesh K Das; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2018-02-27       Impact factor: 6.384

9.  Intricacies for posttranslational tumor-targeted cytokine gene therapy.

Authors:  Jeffry Cutrera; Denada Dibra; Arun Satelli; Xuexing Xia; Shulin Li
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

Review 10.  Gene Therapies for Cancer: Strategies, Challenges and Successes.

Authors:  Swadesh K Das; Mitchell E Menezes; Shilpa Bhatia; Xiang-Yang Wang; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.